Skip to main content
Erschienen in: Pituitary 1/2012

01.03.2012

Cushing’s syndrome: diagnosis and surveillance using salivary cortisol

verfasst von: Hershel Raff

Erschienen in: Pituitary | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

This short review summarizes the use of late-night salivary cortisol measurement in the diagnosis of Cushing’s syndrome, in the evaluation of patients with adrenal incidentalomas, and in monitoring of post-operative patients, with a focus on the different assay methodologies currently in common use. The focus is on recent studies identified by literature searches using Ovid Medline and Google Scholar as well as analysis of several recent review articles on the topic. Measurement of late night salivary cortisol (LNSC) has an excellent sensitivity and specificity for the diagnosis of Cushing’s syndrome regardless of the assay methodology used. Immunoassays have the advantage of simplicity, low cost, and small sample volume requirement, while liquid chromatography-tandem mass spectrometry has the advantage of a high specificity for cortisol and the ability to measure cortisone. The overnight dexamethasone suppression test appears to be superior to LNSC measurement in the evaluation of patients with adrenal incidentalomas. LNSC measurement is an excellent approach to monitor post-operative Cushing’s disease patients for surgical failure or recurrence. Salivary cortisol is most useful as the initial test when Cushing’s syndrome is suspected and for periodic patient monitoring after pituitary surgery for Cushing’s disease.
Literatur
1.
Zurück zum Zitat Raff H, Findling JW (2003) A physiologic approach to diagnosis of the Cushing syndrome. Ann Intern Med 138:980–991PubMed Raff H, Findling JW (2003) A physiologic approach to diagnosis of the Cushing syndrome. Ann Intern Med 138:980–991PubMed
2.
Zurück zum Zitat Carroll T, Raff H, Findling JW (2008) Late-night salivary cortisol measurement in the diagnosis of Cushing’s syndrome. Nat Clin Pract Endocrinol Metab 4:344–350PubMedCrossRef Carroll T, Raff H, Findling JW (2008) Late-night salivary cortisol measurement in the diagnosis of Cushing’s syndrome. Nat Clin Pract Endocrinol Metab 4:344–350PubMedCrossRef
3.
Zurück zum Zitat Findling JW, Raff H (2006) Cushing’s syndrome: important issues in diagnosis and management. J Clin Endocrinol Metab 91:3746–3753PubMedCrossRef Findling JW, Raff H (2006) Cushing’s syndrome: important issues in diagnosis and management. J Clin Endocrinol Metab 91:3746–3753PubMedCrossRef
4.
Zurück zum Zitat Findling JW, Raff H (2001) Diagnosis and differential diagnosis of Cushing’s syndrome. Endocrinol Metab Clin North Am 30:729–747PubMedCrossRef Findling JW, Raff H (2001) Diagnosis and differential diagnosis of Cushing’s syndrome. Endocrinol Metab Clin North Am 30:729–747PubMedCrossRef
5.
Zurück zum Zitat Findling JW, Raff H (1999) Newer diagnostic techniques and problems in Cushing’s disease. Endocrinol Metab Clin North Am 28:191–210PubMedCrossRef Findling JW, Raff H (1999) Newer diagnostic techniques and problems in Cushing’s disease. Endocrinol Metab Clin North Am 28:191–210PubMedCrossRef
6.
Zurück zum Zitat Findling JW, Raff H (2005) Screening and diagnosis of Cushing’s syndrome. Endocrinol Metab Clin North Am 34:385–402PubMedCrossRef Findling JW, Raff H (2005) Screening and diagnosis of Cushing’s syndrome. Endocrinol Metab Clin North Am 34:385–402PubMedCrossRef
7.
Zurück zum Zitat Raff H (2009) Utility of salivary cortisol measurement in Cushing’s syndrome and adrenal insufficiency. J Clin Endocrinol Metab 94:3647–3655PubMedCrossRef Raff H (2009) Utility of salivary cortisol measurement in Cushing’s syndrome and adrenal insufficiency. J Clin Endocrinol Metab 94:3647–3655PubMedCrossRef
8.
Zurück zum Zitat Raff H (2004) Role of salivary cortisol determinations in the diagnosis of Cushing syndrome. Curr Opin Endocrinol Diab 11:271–275CrossRef Raff H (2004) Role of salivary cortisol determinations in the diagnosis of Cushing syndrome. Curr Opin Endocrinol Diab 11:271–275CrossRef
9.
Zurück zum Zitat Carroll TB, Findling JW (2010) The diagnosis of Cushing’s syndrome. Rev Endocr Metab Disord 11:147–153PubMedCrossRef Carroll TB, Findling JW (2010) The diagnosis of Cushing’s syndrome. Rev Endocr Metab Disord 11:147–153PubMedCrossRef
10.
Zurück zum Zitat Alexandraki KI, Grossman AB (2010) Novel insights in the diagnosis of Cushing’s syndrome. Neuroendocrinology 92:35–43PubMedCrossRef Alexandraki KI, Grossman AB (2010) Novel insights in the diagnosis of Cushing’s syndrome. Neuroendocrinology 92:35–43PubMedCrossRef
11.
Zurück zum Zitat Yao KJ, Moss HB, Kirillova GP (1998) Determination of salivary cortisol by nonisotopic immunoassay. Clin Biochem 31:187–190PubMedCrossRef Yao KJ, Moss HB, Kirillova GP (1998) Determination of salivary cortisol by nonisotopic immunoassay. Clin Biochem 31:187–190PubMedCrossRef
12.
Zurück zum Zitat Gatti R, Antonelli G, Prearo M, Spinella P, Cappellin E, De Palo EF (2009) Cortisol assays and diagnostic laboratory procedures in human biological fluids. Clin Biochem 42:1205–1217PubMedCrossRef Gatti R, Antonelli G, Prearo M, Spinella P, Cappellin E, De Palo EF (2009) Cortisol assays and diagnostic laboratory procedures in human biological fluids. Clin Biochem 42:1205–1217PubMedCrossRef
13.
Zurück zum Zitat Carrozza C, Corsello SM, Paragliola RM, Ingraudo F, Palumbo S, Locantore P, Sferrazza A, Pontecorvi A, Zuppi C (2010) Clinical accuracy of midnight salivary cortisol measured by automated electrochemiluminescence immunoassay method in Cushing’s syndrome. Ann Clin Biochem 47:228–232PubMedCrossRef Carrozza C, Corsello SM, Paragliola RM, Ingraudo F, Palumbo S, Locantore P, Sferrazza A, Pontecorvi A, Zuppi C (2010) Clinical accuracy of midnight salivary cortisol measured by automated electrochemiluminescence immunoassay method in Cushing’s syndrome. Ann Clin Biochem 47:228–232PubMedCrossRef
14.
Zurück zum Zitat Beko G, Varba I, Glaz E, Sereg M, Feldman K, Toth M, Racz K, Patocs A (2010) Cutoff values of midnight salivary cortisol for the diagnosis of overt hypercortisolism are highly influenced by methods. Clin Chim Acta 411:364–367PubMedCrossRef Beko G, Varba I, Glaz E, Sereg M, Feldman K, Toth M, Racz K, Patocs A (2010) Cutoff values of midnight salivary cortisol for the diagnosis of overt hypercortisolism are highly influenced by methods. Clin Chim Acta 411:364–367PubMedCrossRef
15.
Zurück zum Zitat Yaneva M, Kirilov G, Zacharieva S (2009) Midnight salivary cortisol, measured by highly sensitive electrochemiluminescence immunoassay, for the diagnosis of Cushing’s syndrome. Central Eur J Med 4:59–64CrossRef Yaneva M, Kirilov G, Zacharieva S (2009) Midnight salivary cortisol, measured by highly sensitive electrochemiluminescence immunoassay, for the diagnosis of Cushing’s syndrome. Central Eur J Med 4:59–64CrossRef
16.
Zurück zum Zitat Chiu SK, Collier CP, Clark AF, Wynn-Edwards KE (2003) Salivary cortisol on ROCHE Elecsys immunoassay system: pilot biological variation studies. Clin Biochem 36:211–214PubMedCrossRef Chiu SK, Collier CP, Clark AF, Wynn-Edwards KE (2003) Salivary cortisol on ROCHE Elecsys immunoassay system: pilot biological variation studies. Clin Biochem 36:211–214PubMedCrossRef
17.
Zurück zum Zitat Hansen AM, Garde AH, Christensen JM, Eller NH, Netterstrøm B (2003) Evaluation of a radioimmunoassay and establishment of a reference interval for salivary cortisol in healthy subjects in Denmark. Scand J Clin Lab Invest 63:303–310PubMedCrossRef Hansen AM, Garde AH, Christensen JM, Eller NH, Netterstrøm B (2003) Evaluation of a radioimmunoassay and establishment of a reference interval for salivary cortisol in healthy subjects in Denmark. Scand J Clin Lab Invest 63:303–310PubMedCrossRef
18.
Zurück zum Zitat Baid SK, Sinaii N, Wade M, Rubino D, Nieman LK (2007) Radioimmunoassay and tandem mass spectrometry measurement of bedtime salivary cortisol levels: a comparison of assays to establish hypercortisolism. J Clin Endocrinol Metab 92:3102–3107PubMedCrossRef Baid SK, Sinaii N, Wade M, Rubino D, Nieman LK (2007) Radioimmunoassay and tandem mass spectrometry measurement of bedtime salivary cortisol levels: a comparison of assays to establish hypercortisolism. J Clin Endocrinol Metab 92:3102–3107PubMedCrossRef
19.
Zurück zum Zitat Vogeser M, Durner J, Seliger E, Auernhammer C (2006) Measurement of late-night salivary cortisol with an automated immunoassay system. Clin Chem Lab Med 44:1441–1445PubMedCrossRef Vogeser M, Durner J, Seliger E, Auernhammer C (2006) Measurement of late-night salivary cortisol with an automated immunoassay system. Clin Chem Lab Med 44:1441–1445PubMedCrossRef
20.
Zurück zum Zitat Sakihara S, Kageyhama K, Oki Y, Doi M, Iwasaki Y, Takayasu S, Moriyama T, Terui K, Nibawara T, Hirata Y, Hashimoto K, Suda T (2010) Evaluation of plasma, salivary, and urinary cortisol levels for diagnosis of Cushing’s syndrome. Endocr J 57:331–337PubMedCrossRef Sakihara S, Kageyhama K, Oki Y, Doi M, Iwasaki Y, Takayasu S, Moriyama T, Terui K, Nibawara T, Hirata Y, Hashimoto K, Suda T (2010) Evaluation of plasma, salivary, and urinary cortisol levels for diagnosis of Cushing’s syndrome. Endocr J 57:331–337PubMedCrossRef
21.
Zurück zum Zitat Perogamvros I, Owen LJ, Newell-Price J, Ray DW, Trainer PJ, Keevil B (2009) Simultaneous measurement of cortisol and cortisone in human saliva using liquid chromatography-tandem mass spectrometry: application in basal and stimulated conditions. J Chromatogr B 877:3771–3775CrossRef Perogamvros I, Owen LJ, Newell-Price J, Ray DW, Trainer PJ, Keevil B (2009) Simultaneous measurement of cortisol and cortisone in human saliva using liquid chromatography-tandem mass spectrometry: application in basal and stimulated conditions. J Chromatogr B 877:3771–3775CrossRef
22.
Zurück zum Zitat Lee S, Kwon S, Shin HJ, Lim HS, Singh RJ, Lee KR, Kim YJ (2010) Simultaneous quantitative analysis of salivary cortisol and cortisone in Korean adults using LC-MS/MS. BMB Reports 43:506–511PubMedCrossRef Lee S, Kwon S, Shin HJ, Lim HS, Singh RJ, Lee KR, Kim YJ (2010) Simultaneous quantitative analysis of salivary cortisol and cortisone in Korean adults using LC-MS/MS. BMB Reports 43:506–511PubMedCrossRef
23.
Zurück zum Zitat Jonsson BAG, Malmberg B, Amilon A, Garde AH, Orbaek P (2003) Determination of cortisol in human saliva using liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr B 784:63–68CrossRef Jonsson BAG, Malmberg B, Amilon A, Garde AH, Orbaek P (2003) Determination of cortisol in human saliva using liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr B 784:63–68CrossRef
24.
Zurück zum Zitat Turpeinen U, Valimaki MJ, Hamalainen E (2009) Determination of salivary cortisol by liquid chromatography-tandem mass spectrometry. Scand J Clin Lab Invest 69:592–597PubMedCrossRef Turpeinen U, Valimaki MJ, Hamalainen E (2009) Determination of salivary cortisol by liquid chromatography-tandem mass spectrometry. Scand J Clin Lab Invest 69:592–597PubMedCrossRef
25.
Zurück zum Zitat Owen LJ, Haslam S, Adaway JE, Wood P, Glenn C, Keevil BG (2010) A simplified liquid chromatography tandem mass spectrometry assay, using on-line solid-phase extraction, for the quantitation of cortisol in saliva and comparison with a routine DELFIA method. Ann Clin Biochem 47:131–136PubMedCrossRef Owen LJ, Haslam S, Adaway JE, Wood P, Glenn C, Keevil BG (2010) A simplified liquid chromatography tandem mass spectrometry assay, using on-line solid-phase extraction, for the quantitation of cortisol in saliva and comparison with a routine DELFIA method. Ann Clin Biochem 47:131–136PubMedCrossRef
26.
Zurück zum Zitat Nelson EA, Palombo EA, Knowles SR (2008) Comparison of evaporation techniques for the preparation of salivary cortisol for analysis by liquid chromatography-electrospray tandem mass spectrometry. Clin Biochem 41:1413–1416PubMedCrossRef Nelson EA, Palombo EA, Knowles SR (2008) Comparison of evaporation techniques for the preparation of salivary cortisol for analysis by liquid chromatography-electrospray tandem mass spectrometry. Clin Biochem 41:1413–1416PubMedCrossRef
27.
Zurück zum Zitat Kataoka H, Matsuura E, Mitani K (2007) Determination of cortisol in human saliva by automated in-tube solid-phase microextraction coupled with liquid chromatography-mass spectrometry. J Pharmaceut Biomed Anal 44:160–165CrossRef Kataoka H, Matsuura E, Mitani K (2007) Determination of cortisol in human saliva by automated in-tube solid-phase microextraction coupled with liquid chromatography-mass spectrometry. J Pharmaceut Biomed Anal 44:160–165CrossRef
28.
Zurück zum Zitat Zerikly RK, Amiri L, Faiman C, Gupta M, Singh RJ, Nutter B, Kennedy L, Hatipoglu B, Weil RJ, Hamrahian AH (2010) Diagnostic characteristics of late-night salivary cortisol using liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 95:4555–4559PubMedCrossRef Zerikly RK, Amiri L, Faiman C, Gupta M, Singh RJ, Nutter B, Kennedy L, Hatipoglu B, Weil RJ, Hamrahian AH (2010) Diagnostic characteristics of late-night salivary cortisol using liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 95:4555–4559PubMedCrossRef
29.
Zurück zum Zitat DePalo EF, Antonelli G, Benetazzo A, Prearo M, Gatti R (2009) Human saliva cortisone and cortisol simultaneous analysis using reverse phase HPLC technique. Clin Chim Acta 405:60–65CrossRef DePalo EF, Antonelli G, Benetazzo A, Prearo M, Gatti R (2009) Human saliva cortisone and cortisol simultaneous analysis using reverse phase HPLC technique. Clin Chim Acta 405:60–65CrossRef
30.
Zurück zum Zitat Raff H, Sluss PM (2008) Pre-analytical issues for testosterone and estradiol assays. Steroids 73:1297–1304PubMedCrossRef Raff H, Sluss PM (2008) Pre-analytical issues for testosterone and estradiol assays. Steroids 73:1297–1304PubMedCrossRef
31.
Zurück zum Zitat Broderick JE, Arnold D, Kudielka BM, Kirschbaum C (2004) Salivary cortisol sampling compliance: comparison of patients and healthy volunteers. Psychoneuroendocrinology 29:636–650PubMedCrossRef Broderick JE, Arnold D, Kudielka BM, Kirschbaum C (2004) Salivary cortisol sampling compliance: comparison of patients and healthy volunteers. Psychoneuroendocrinology 29:636–650PubMedCrossRef
32.
Zurück zum Zitat Perogamvros I, Keevil BG, Ray DW, Trainer PJ (2010) Salivary cortisone is a potential biomarker for serum free cortisol. J Clin Endocrinol Metab 95:4951–4958PubMedCrossRef Perogamvros I, Keevil BG, Ray DW, Trainer PJ (2010) Salivary cortisone is a potential biomarker for serum free cortisol. J Clin Endocrinol Metab 95:4951–4958PubMedCrossRef
33.
Zurück zum Zitat Raff H (2008–2009) Cushing’s syndrome: diagnosis using late-night salivary cortisol measurement. Clin Lab Int (CLI) 12:6–8 (Dec 2008–Jan 2009) Raff H (2008–2009) Cushing’s syndrome: diagnosis using late-night salivary cortisol measurement. Clin Lab Int (CLI) 12:6–8 (Dec 2008–Jan 2009)
34.
Zurück zum Zitat Kivlighan KT, Granger DA, Schwartz EB, Nelson V, Curran M, Shirtcliff EA (2004) Quantifying blood leakage into the oral mucosa and its effects on the measurement of cortisol, dehydroepiandrosterone, and testosterone in saliva. Horm Behav 46:39–46PubMedCrossRef Kivlighan KT, Granger DA, Schwartz EB, Nelson V, Curran M, Shirtcliff EA (2004) Quantifying blood leakage into the oral mucosa and its effects on the measurement of cortisol, dehydroepiandrosterone, and testosterone in saliva. Horm Behav 46:39–46PubMedCrossRef
35.
Zurück zum Zitat Nunes ML, Vattaut S, Corcuff JB, Rault A, Loiseau H, Gatta B, Valli N, Letenneur L, Tabarin A (2009) Late-night salivary cortisol for diagnosis of overt and subclinical Cushing’s syndrome in hospitalized and ambulatory patients. J Clin Endocrinol Metab 94:456–462PubMedCrossRef Nunes ML, Vattaut S, Corcuff JB, Rault A, Loiseau H, Gatta B, Valli N, Letenneur L, Tabarin A (2009) Late-night salivary cortisol for diagnosis of overt and subclinical Cushing’s syndrome in hospitalized and ambulatory patients. J Clin Endocrinol Metab 94:456–462PubMedCrossRef
36.
Zurück zum Zitat Cardoso EM, Arregger AL, Tumilasci OR, Contreras LN (2009) Diagnostic value of salivary cortisol in Cushing’s syndrome (CS). Clin Endocrinol (Oxf) 70:516–521CrossRef Cardoso EM, Arregger AL, Tumilasci OR, Contreras LN (2009) Diagnostic value of salivary cortisol in Cushing’s syndrome (CS). Clin Endocrinol (Oxf) 70:516–521CrossRef
37.
Zurück zum Zitat Mullan K, Black N, Thiraviaraj A, Bell PM, Burgess C, Hunter SJ, McCance DR, Leslie H, Sheridan B, Atkinson AB (2010) Is there value in routine screening for Cushing’s syndrome in patients with diabetes. J Clin Endocrinol Metab 95:2262–2265PubMedCrossRef Mullan K, Black N, Thiraviaraj A, Bell PM, Burgess C, Hunter SJ, McCance DR, Leslie H, Sheridan B, Atkinson AB (2010) Is there value in routine screening for Cushing’s syndrome in patients with diabetes. J Clin Endocrinol Metab 95:2262–2265PubMedCrossRef
38.
Zurück zum Zitat Newsome S, Chen K, Hoang J, Wilson JD, Potter JM, Hickman PE (2008) Cushing’s syndrome in a clinic population with diabetes. Intern Med J 38:178–182PubMedCrossRef Newsome S, Chen K, Hoang J, Wilson JD, Potter JM, Hickman PE (2008) Cushing’s syndrome in a clinic population with diabetes. Intern Med J 38:178–182PubMedCrossRef
39.
Zurück zum Zitat Baid SK, Rubino D, Sinaii N, Ramsey S, Frank A, Nieman LK (2009) Specificity of screening tests for Cushing’s syndrome in an overweight and obese population. J Clin Endocrinol Metab 94:3857–3864PubMedCrossRef Baid SK, Rubino D, Sinaii N, Ramsey S, Frank A, Nieman LK (2009) Specificity of screening tests for Cushing’s syndrome in an overweight and obese population. J Clin Endocrinol Metab 94:3857–3864PubMedCrossRef
40.
Zurück zum Zitat Carroll T, Raff H, Findling JW (2009) Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis. Endocr Pract 15:335–342PubMedCrossRef Carroll T, Raff H, Findling JW (2009) Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis. Endocr Pract 15:335–342PubMedCrossRef
41.
Zurück zum Zitat Kidambi S, Raff H, Findling JW (2007) Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing’s syndrome. Eur J Endocrinol 157:725–731PubMedCrossRef Kidambi S, Raff H, Findling JW (2007) Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing’s syndrome. Eur J Endocrinol 157:725–731PubMedCrossRef
42.
Zurück zum Zitat Bardet S, Rohmer V, Boux de Casson F, Coffin C, Ronci N, Sabatier JP, Lecomte P, Audran M, Henry-Amar M, Tabarin A (2002) Bone density and biochemical bone markers in patients with adrenal incidentalomas: effect of subclinical hypercortisolism. Rev Méd Interne 23:508–517PubMedCrossRef Bardet S, Rohmer V, Boux de Casson F, Coffin C, Ronci N, Sabatier JP, Lecomte P, Audran M, Henry-Amar M, Tabarin A (2002) Bone density and biochemical bone markers in patients with adrenal incidentalomas: effect of subclinical hypercortisolism. Rev Méd Interne 23:508–517PubMedCrossRef
43.
Zurück zum Zitat Chiodini I (2011) Diagnosis and treatment of subclinical hypercortisolism. J Clin Endocrinol Metab 96:1223–1236 Chiodini I (2011) Diagnosis and treatment of subclinical hypercortisolism. J Clin Endocrinol Metab 96:1223–1236
44.
Zurück zum Zitat Chiodini I, Morelli V, Masserini B, Salcuni AS, Eller-Vainicher C, Viti R, Coletti F, Guglielmi G, Battista C, Carnevale V, Iorio L, Beck-Peccoz P, Arosio M, Ambrosi B, Scillitani A (2009) Bone mineral density, prevalence of vertebral fractures, and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian multicenter study. J Clin Endocrinol Metab 94:3207–3214PubMedCrossRef Chiodini I, Morelli V, Masserini B, Salcuni AS, Eller-Vainicher C, Viti R, Coletti F, Guglielmi G, Battista C, Carnevale V, Iorio L, Beck-Peccoz P, Arosio M, Ambrosi B, Scillitani A (2009) Bone mineral density, prevalence of vertebral fractures, and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian multicenter study. J Clin Endocrinol Metab 94:3207–3214PubMedCrossRef
45.
Zurück zum Zitat Morelli V, Vainicher CE, Salcuni AS, Coletti F, Iorio L, Muscogiuri G, Della Casa S, Arosio M, Ambrosi B, Beck-Peccoz P, Chiodini I (2011) Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: a multicenter longitudinal study. J Bone Miner Res. doi:10.1002/jbmr.398 Morelli V, Vainicher CE, Salcuni AS, Coletti F, Iorio L, Muscogiuri G, Della Casa S, Arosio M, Ambrosi B, Beck-Peccoz P, Chiodini I (2011) Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: a multicenter longitudinal study. J Bone Miner Res. doi:10.​1002/​jbmr.​398
46.
Zurück zum Zitat Masserini B, Morelli V, Bergamaschi S, Ermetici F, Eller-Vainicher C, Barbieri AM, Maffini MA, Scillitani A, Ambrosi B, Beck-Peccoz P, Chiodini I (2009) The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma. Eur J Endocrinol 160:87–92PubMedCrossRef Masserini B, Morelli V, Bergamaschi S, Ermetici F, Eller-Vainicher C, Barbieri AM, Maffini MA, Scillitani A, Ambrosi B, Beck-Peccoz P, Chiodini I (2009) The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma. Eur J Endocrinol 160:87–92PubMedCrossRef
47.
Zurück zum Zitat Deutschbein T, Unger N, Hinrichs J, Walz MK, Mann K, Petersenn S (2009) Late-night and low-dose dexamethasone-suppressed cortisol and serum for the diagnosis of cortisol-secretion adrenal adenomas. Eur J Endocrinol 161:747–753PubMedCrossRef Deutschbein T, Unger N, Hinrichs J, Walz MK, Mann K, Petersenn S (2009) Late-night and low-dose dexamethasone-suppressed cortisol and serum for the diagnosis of cortisol-secretion adrenal adenomas. Eur J Endocrinol 161:747–753PubMedCrossRef
48.
Zurück zum Zitat Sereg M, Toke J, Patocs A, Varga I, Igaz P, Szucs N, Horanyi J, Pusztai P, Czirjak S, Glaz E, Racz K, Toth M (2011) Diagnostic performance of salivary cortisol and serum osteocalcin measurements in patients with overt and subclinical Cushing’s syndrome. Steroids 76:38–42PubMedCrossRef Sereg M, Toke J, Patocs A, Varga I, Igaz P, Szucs N, Horanyi J, Pusztai P, Czirjak S, Glaz E, Racz K, Toth M (2011) Diagnostic performance of salivary cortisol and serum osteocalcin measurements in patients with overt and subclinical Cushing’s syndrome. Steroids 76:38–42PubMedCrossRef
49.
Zurück zum Zitat Aghi MK, Petit J, Chapman P, Loeffler J, Klibanski A, Biller BM, Swearingen B (2008) Management of recurrent and refractory Cushing’s disease with reoperation and/or proton beam radiosurgery. Clin Neurosurg 55:141–144PubMed Aghi MK, Petit J, Chapman P, Loeffler J, Klibanski A, Biller BM, Swearingen B (2008) Management of recurrent and refractory Cushing’s disease with reoperation and/or proton beam radiosurgery. Clin Neurosurg 55:141–144PubMed
50.
Zurück zum Zitat Carrasco CA, Coste J, Guignat L, Groussin L, Dugué MA, Gaillard S, Bertagna X, Bertherat J (2008) Midnight salivary cortisol determination for assessing the outcome of transsphenoidal surgery in Cushing’s disease. J Clin Endocrinol Metab 93:4728–4734PubMedCrossRef Carrasco CA, Coste J, Guignat L, Groussin L, Dugué MA, Gaillard S, Bertagna X, Bertherat J (2008) Midnight salivary cortisol determination for assessing the outcome of transsphenoidal surgery in Cushing’s disease. J Clin Endocrinol Metab 93:4728–4734PubMedCrossRef
Metadaten
Titel
Cushing’s syndrome: diagnosis and surveillance using salivary cortisol
verfasst von
Hershel Raff
Publikationsdatum
01.03.2012
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 1/2012
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-011-0333-0

Weitere Artikel der Ausgabe 1/2012

Pituitary 1/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.